AdTab (previously Lotilaner Elanco) RSSAuthorisedThis medicine is authorised for use in the European UnionlotilanerMedicineVeterinaryAuthorised
Page contentsOverviewProduct detailsAuthorisation detailsAssessment historyNews on AdTab (previously Lotilaner Elanco)More information on AdTab (previously Lotilaner Elanco)OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website.Product details Name of medicine AdTab (previously Lotilaner Elanco) Active substance lotilaner International non-proprietary name (INN) or common name lotilaner Pharmacotherapeutic groupEctoparasiticides for systemic useIsoxazolinesAuthorisation details EMA product number EMEA/V/C/006030 Assessment historyInitial marketing authorisation documentsCVMP summary of positive opinion for Lotilaner ElancoAdoptedReference Number: EMA/CVMP/623416/2022 English (EN) (132.78 KB - PDF)First published: 15/07/2022ViewNews on AdTab (previously Lotilaner Elanco)Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-14 February 202416/02/2024Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 202317/02/2023Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 12-14 July 202215/07/2022More information on AdTab (previously Lotilaner Elanco)Lotilaner Elanco - opinion on variation to marketing authorisationThis page was last updated on 15/02/2024Share this page